- Slow traction clouding GSK-Dr Reddy's expansive deal?
- GSK plans to divest old drugs except in emerging markets
- Big deals in Q1, but bigger deals to come
- Rejections All Around: Mylan to Teva, Perrigo to Mylan
COMMENT Other Informa Comment
- PROFILE: Vas Narasimhan on many Novartis roles, extinction fears and Hilleman influences
- Scrip 100: Alcon's Jeff George, 'Google guys blew us away'
JOB OF THE WEEK Promote your job vacancy